Ironwood Pharmaceuticals
IRWD
IRWD
251 hedge funds and large institutions have $1.91B invested in Ironwood Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 87 increasing their positions, 94 reducing their positions, and 26 closing their positions.
Holders
251
Holders Change
+3
Holders Change %
+1.21%
% of All Funds
3.68%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
32
Increased
87
Reduced
94
Closed
26
Calls
$24.5M
Puts
$11.5M
Net Calls
+$13M
Net Calls Change
+$12.4M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$49.1M |
| 2 |
AC
2
Armistice Capital
New York
|
$65.2M |
| 3 |
3
Man Group
London,
United Kingdom
|
$16.3M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$183M |
| 5 |
CS
5
Credit Suisse
Zurich,
Switzerland
|
$64.2M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PFBT
276
Parkside Financial Bank & Trust
Saint Louis,
Missouri
| – | – | -131 | Closed |
|
|
FHA
277
First Horizon Advisors
Memphis,
Tennessee
| – | – | -84 | Closed |
|
|
CM
278
Caption Management
Oklahoma City,
Oklahoma
| – | – | – | – |
|
|
CFGS
279
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
SCM
280
Sio Capital Management
New York
| – | – | – | – |
|
|
HCP
281
Hexagon Capital Partners
Rogers,
Arkansas
| – | – | – | – |
|
282
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|